laledincasarcikli retweeted
📢 #EACVI2026
A key 🌍 platform where #CVImaging comes together to shape the future of our field.
📍 Milan | 📅 3–5 Dec
📝 Abstract: 21 May
📝 Clinical case: 2 June
Why should you submit your work?
Hear from Prof @VDelgadoGarcia 👇
🔗 escardio.org/events/congress…
@NAjmoneMarsan @rmanka_ @carpenter_jp @LunaGargani @andgiannopmd @PezelT @anatimoteo46040 @alessia_gimelli @EHJIMPEiC @EHJCVIEiC @Sarah_Moharem @denisamuraru @s_e_petersen @VDelgadoGarcia
laledincasarcikli retweeted
Amazing show case of Infective Endocarditis spectrum at clinical case corner #EACVI2025 @EACVIPresident
laledincasarcikli retweeted
🫀Different types of VSD🫀
🧭 Left-right & cranio-caudal 3D orientation #echofirst #CHD
@WGACHDChair @iamritu @DavidWienerMD @CASivaram1 @OungSavly @Prasannasimha @CardioNeo @loomba_rohit @DrRajeshG1 @EACVIPresident
Grateful for the chance to meet my inspiring and supportive teachers at #ESCCongress2025 — the biggest stage of European cardiology 🙌@LaleTokgozoglu @MeralKayikcoglu
laledincasarcikli retweeted
All you need to know about the latest hot science in #HeartFailure is brought to you by @lamcardio and @MarcoMetra, and moderated by @leventpy👇
DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalised for Acute Heart Failure
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction
ODYSSEY-HCM: Mavacamten in nHCM
MAPLE-HCM: aficamten vs metoprolol in oHCM
#ESCCongress #ESCsnacks
Just saying ‘severe TR’ is not enough — defining the mechanism (primary vs secondary) is crucial as it guides therapy. 🫀 3D assessment of the tricuspid annulus is recommended, since severe annular dilation is the leading cause of TTVR failure.#esc2025 #EACVI @denisamuraru
CV imaging in elder poses unique challenges: contrast safety, patient cooperation, and cognitive decline. Recent Diast Dysfxn guideline emphasize that structural changes due to aging are not just ‘normal’ but integral to cardiac remodeling #ESC2025 @NAjmoneMarsan @EACVIPresident
laledincasarcikli retweeted
1/n New ESC / EACT Guidelines on Valvular Heart Disease published today - 102 pages.
Read here: academic.oup.com/eurheartj/a…
Some changes from previous…
This is a tweetorial
@DrMarthaGulati @mmamas1973 @purviparwani @Hragy @AnastasiaSMihai @gbiondizoccai @HanCardiomd @justvick
laledincasarcikli retweeted
The 10 key points of the 2025 ESC guidelines on myocarditis and pericarditis presented today and just published on the EHJ: Eur Heart J. 2025 Aug 29:ehaf192. doi: 10.1093/eurheartj/ehaf192.
New definition alert 🚨from MPD guidelines 2025: IMPS = Inflammatory Myocardial–Pericardial Syndromes. As expected, CMR is key — detecting myocardial involvement, assessing reversibility of damage, and guiding tailored therapy @ImazioMassimo @drozgeozden @whyCMR #ESC2025
laledincasarcikli retweeted
Join Professor @leylaelifsade , Professor Kristina Haugaa and @drozgeozden for the next #EACVI Webinar on Algorithmic approach to left ventricular hypertrophy on 22 September.
Free for #EACVI Silver members and FEACVI.
esc365.escardio.org/event/19…
@DrGEMandoli @elenadpelaez @BirkhoelzerS @pfelissamburu @GosiaWamil @WilliamKokFaiK1 @MSBBrandao @hrt01a @slumberbell
@denisamuraru @s_e_petersen @VDelgadoGarcia
laledincasarcikli retweeted
Replying to @DrRajeshG1 @ecgrhythms
Was absolutely fascinated behind the physics when I first read it!
asecho.org/wp-content/upload…
“PADIT” acronym denotes the factors that increase the risk of CIED related infection . Excellent talk from @hahn_rt #PCRimaging
doi.org/10.1016/j.jacc.2024.…
laledincasarcikli retweeted
Our ARTEMIS (A RegisTry of pEripartuM cardIomyopathy in Turkish patientS) Study on #PPCM just online in #ArchivesTSC October issue!
'Baseline Characteristics & Clinical Insights from the #ARTEMIS Registry: A Comprehensive Study of Peripartum Cardiomyopathy in #Türkiye.'
This first national PPCM registry offers vital insights into the management of this #raredisease.
➡️ARTEMIS—named after the goddess of childbirth—includes 293 women across 55 investigators from 44 centers in 24 cities.
➡️Our findings reveal a potentially high prevalence, though awareness remains low among patients & cardiologists.
Link: jag.journalagent.com/tkd/pdf…
Thanks to all dedicated ARTEMIS investigators
@Murat32663337 @cardioceptor @drheartfailure
#Cardiology #PPCM #ARTEMISRegistry #WomensHealth #Cardiology #Pregnancy #HeartHealth #MedicalResearch @drmuratakcay
@Sliwa1Karen 🧿🙏❤️ @HFA_President @escardio
@tugceinci88
#mitocondria #cardioX #CardioTwitter #heartfailure #CardioX #CardioTwitter #Turkiye
@dilek_g_ural @LaleTokgozoglu
@TKDResmi @TKDsosyal
@umityasarsinan1
@cerol191
#Cardiology #ASCVD #Lipoprotein @kugurmert
@temizhan
@benayozbay
@ErinMichos @DrMarthaGulati
@leventpy
@AslangerE @NurglKeser6 @drheartfailure @DuyguKocyigitMD
@serdarbozyel @mdlaledinc
@m_degertekin @dilek_g_ural @leventpy
@ozlemyt @AslangerE @kugurmert
@drpablocorral @pabeda1
@PeroneFrancesco
@ProfKausikRay
@BNordestgaard @society_eas @MutazAlsabah
@FedericaFogacci
@maciejbanach
@drheartfailure
@mdlaledinc
@HanCardiomd
@Hragy @society_eas
#Cardiosister #CardioTwitter #CardioX #HeartHealth @SABOURETCardio
@ErinMichos @DrMarthaGulati
#HFA
laledincasarcikli retweeted
Türk kardiyolojisinin HFA 2024 temsilcileri ve kalp yetersizliğinin duayen hocalarıyla
@cardioceptor
@seldamurat_dr
@temizhan
@anllsahin
@mdlaledinc
@tugceinci88






































